HISAMITSU PHARMACEUTICAL CO.,INC. Logo

HISAMITSU PHARMACEUTICAL CO.,INC.

A global leader in transdermal drug delivery systems for OTC and prescription pain relief.

4530 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
鳥栖市田代大官町408番地
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Hisamitsu Pharmaceutical Co., Inc. is a multinational pharmaceutical corporation engaged in the research, development, manufacture, and sale of prescription and over-the-counter (OTC) products. The company is a global leader in pain relief solutions, specializing in transdermal drug delivery systems. Its core portfolio features external analgesic and anti-inflammatory preparations, including well-known patches, plasters, and poultices. Hisamitsu actively pursues innovation in its field, with ongoing clinical research into next-generation technologies like microneedle drug delivery systems. Established in 1834, the company leverages its long history and expertise to market its therapeutic products worldwide.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for HISAMITSU PHARMACEUTICAL CO.,INC. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-03 08:36
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.0 KB
2025-08-05 08:45
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 24.1 KB
2025-05-23 08:00
Regulatory News Service
確認書
Japanese 9.5 KB
2025-05-23 07:58
Regulatory News Service
内部統制報告書-第123期(2024/03/01-2025/02/28)
Japanese 24.0 KB
2025-05-23 07:55
Annual Report
有価証券報告書-第123期(2024/03/01-2025/02/28)
Japanese 1.7 MB
2025-05-23 07:44
Regulatory News Service
臨時報告書
Japanese 28.3 KB
2024-10-11 08:12
Regulatory News Service
確認書
Japanese 9.2 KB
2024-10-11 08:08
Interim Report
半期報告書-第123期(2024/03/01-2025/02/28)
Japanese 244.4 KB
2024-07-12 08:12
Regulatory News Service
確認書
Japanese 9.2 KB
2024-07-12 08:09
Quarterly Report
四半期報告書-第123期第1四半期(2024/03/01-2024/05/31)
Japanese 179.7 KB
2024-05-24 08:14
Regulatory News Service
確認書
Japanese 9.5 KB
2024-05-24 08:12
Regulatory News Service
内部統制報告書-第122期(2023/03/01-2024/02/29)
Japanese 24.1 KB
2024-05-24 08:10
Annual Report
有価証券報告書-第122期(2023/03/01-2024/02/29)
Japanese 1.7 MB
2024-05-24 08:05
Regulatory News Service
臨時報告書
Japanese 29.5 KB
2024-01-12 07:06
Regulatory News Service
確認書
Japanese 9.2 KB

Automate Your Workflow. Get a real-time feed of all HISAMITSU PHARMACEUTICAL CO.,INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for HISAMITSU PHARMACEUTICAL CO.,INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
bioMérieux Logo
Provides in vitro diagnostic solutions for clinical and industrial microbiology.
France BIM
BioPorto Logo
IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.
Denmark BIOPOR
Biosergen AB Logo
Developing novel antifungal drugs for life-threatening infections in immunocompromised patients.
Sweden BIOSGN
Bio Solution Co.,Ltd. Logo
Develops cell therapies for degenerative diseases and supplies bio-lab reagents for R&D.
South Korea 086820
Biosynex Logo
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
France ALBIO
Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany BIO3
Biotika A.S. Logo
Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.
Slovakia BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom BVXP
Bioversys N Logo
Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.
Switzerland BIOV

Talk to a Data Expert

Have a question? We'll get back to you promptly.